Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-01 Purchase | 2022-06-02 4:05 pm | Rain Therapeutics Inc. | RAIN | Vellanki Avanish Chairman and CEO 10% Owner | 25,000 | $2.29 | $57,250 | 2,471,627 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-26 Disposition | 2024-01-26 4:34 pm | N/A N/A | Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO | 932,482 | $0 | 0 (Direct) | View |
| 2024-01-26 Equity Swap | 2024-01-26 4:34 pm | N/A N/A | Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO | 2,550,910 | $0 | 0 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:17 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO | 399,750 | $0 | 399,750 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 6:15 pm | N/A 2033-02-15 | Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO | 318,600 | $0 | 318,600 (Direct) | View |
| 2022-04-14 Gift | 2022-04-15 4:30 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Vellanki Avanish Chairman and CEO 10% Owner | 59,618 | $0 | 2,525,910 (Indirect) | View |
| 2022-03-11 Exercise | 2022-03-15 3:23 pm | N/A 2030-11-12 | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 14,468 | $0 | 3,007,742 (Direct) | View |
| 2022-03-11 Exercise | 2022-03-15 3:23 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 14,468 | $4 | 3,007,742 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-04 4:30 pm | N/A 2032-02-02 | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 182,300 | $0 | 182,300 (Direct) | View |
| 2021-04-27 Conversion | 2021-04-27 5:01 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 23,320 | $0 | 2,511,442 (Direct) | View |
Ownership | 2021-04-22 7:10 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 0 | $0 | 2,557,742 (Direct) | View |